StockGuru Blog: The Immune Response Corporation – Forming Partnerships is One Key to Stock Value
IMNR - The Immune Response Corporation StockGuru Profile IMNR IMNR has a corporate strategy which involves three steps to achieve success: Within the coming two years to: Complete Phase II for MS and HIV; Form private and public partnerships; Initiate clinical development of second autoimmune product for Psoriasis Successful Phase II Clinical Trial completion should signal strong interest in IMNR. It will be important to keep a close eye on IMNR as they approach this pivotal milestone for not one but two incredibly important drugs which will treat two massive diseases: MS and HIV. The IR103 development plan (link here…